Boardroom Alpha
Boardroom Alpha
COTY · Current Report (Form 8-K) · Filed July 7, 2026

Coty Inc — Current Report (Form 8-K)

Form
8-K
Filed
July 7, 2026
Period
Jul 7, 2026
Ticker
COTY
Accession
0001024305-26-000038
Boardroom Alpha · Filing insights

Coty, Gucci, and Kering terminate Gucci Beauty license early for about $400M; transition includes inventory sale and litigation settlement.

About Coty Inc
Market cap
$2.3B
1Y TSR
−34.9%
3Y TSR
−38.2%
Board grade
C-
Sector
Consumer Defensive
CEO
Markus Strobel
Last annual meeting: Nov 5, 2026 · View full Coty Inc profile →
coty-20260707

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 7, 2026
Coty Inc.

(Exact Name of Registrant as Specified in its Charter)
Delaware001-3596413-3823358
(State or other Jurisdiction
of Incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)
350 Fifth Avenue
New York,
NY
10118
(Address of Principal Executive Offices)(Zip Code)

Registrant’s telephone number, including area code: (212) 389-7300

(Former name or former address, if changed from last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each classTrading symbol(s)Name of each exchange on which registered
Class A Common Stock, $0.01 par valueCOTYNew York Stock Exchange


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company    ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.o




Item 8.01 Other Events
On July 7, 2026, Coty Inc. (the “Company”), Coty International B.V. (“Coty International”), HFC Prestige International Operations Switzerland S.à.R.L (together with the Company and Coty International, the “Coty Group”), Guccio Gucci S.p.A (“Guccio Gucci”), Gucci America Inc (together with Guccio Gucci, “Gucci”) and Kering S.A. (“Kering”) entered into a License Termination and Transition Agreement (the “Termination Agreement”). The Termination Agreement relates to the License Agreement for the exclusive right to manufacture and commercialize beauty products under the Gucci brand (“Gucci Beauty”), dated April 21, 2006, as amended from time to time (the “License Agreement”).
Pursuant to the terms of the Termination Agreement, the License Agreement will terminate on June 30, 2027, one year prior to its originally scheduled expiration, subject to an option to extend the termination date further at Kering’s request (as such date may be extended, the “Anticipated Termination Date”). Under the terms of the Termination Agreement, the Company will receive aggregate consideration of approximately $400 million. The Company received $250 million in cash upon signing the Termination Agreement, and will receive an additional $150 million, subject to a potential holdback of up to $30 million in certain specified circumstances, on the earlier of the Anticipated Termination Date and September 30, 2027. The proceeds are intended to be used to reduce the Company’s debt, reinvest in the Company’s core fragrance and beauty brands, and optimize the Company’s organizational set-up to reflect the new scope of its business.

Coty has also agreed to sell to Kering an amount of Gucci Beauty inventory sufficient to support the transition. The payments for inventory are payable following invoices throughout the transition period.

In connection with the transaction, Coty, Gucci and Kering have agreed to a mutual resolution of all pending litigation and related claims concerning the Gucci Beauty license, allowing the parties to focus on an orderly transition and their respective future strategic priorities.

A copy of the press release announcing this change is attached to this Current Report on Form 8-K as Exhibit 99.1. A copy of the press release is also available on its website at www.investors.coty.com, under the “Investor News” tab.

Item 9.01 Financial Statements and Exhibits

(d)Exhibits:
Exhibit No.
Description
104Cover Page Interactive Data File (embedded within the Inline XBRL document).





SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Coty Inc.
(Registrant)
Date: July 7, 2026
By:
/s/ Kristin Blazewicz
Kristin Blazewicz
Chief Legal Officer, General Counsel and Secretary



From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Coty Inc (COTY)

Reference

Frequently asked questions

When did Coty Inc file this 8-K?
Coty Inc (COTY) filed this Current Report (Form 8-K) with the SEC on July 7, 2026. The accession number assigned by EDGAR is 0001024305-26-000038.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Coty, Gucci, and Kering terminate Gucci Beauty license early for about $400M; transition includes inventory sale and litigation settlement. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Coty Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Coty Inc has filed under CIK 1024305, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer